Rob Felsch
About Rob Felsch
Rob Felsch serves as the Senior Vice President of Finance and Chief Accounting Officer at Ardelyx, Inc. He has over 20 years of experience in finance and accounting within the pharmaceutical industry, having held various leadership roles at companies such as Celgene, Array BioPharma, and IGM Biosciences.
Current Role at Ardelyx
Rob Felsch serves as the Senior Vice President of Finance and Chief Accounting Officer at Ardelyx, Inc. since 2022. In this role, he oversees the financial operations and accounting functions of the company. His responsibilities include managing financial reporting, compliance, and strategic financial planning to support the company's growth objectives.
Previous Experience in Finance
Felsch has held several significant positions in finance and accounting prior to his current role. He worked at IGM Biosciences, Inc. as Senior Vice President Corporate Controller for four months in 2022. At Celgene, he served as Vice President, Head of Internal Audit for one year and held various roles from Senior Manager to Senior Director in Financial Reporting for six years. His experience also includes a position as Vice President, Corporate Controller and FP&A at Array BioPharma Inc. from 2018 to 2020.
Educational Background
Rob Felsch earned a Bachelor of Science degree in Accounting from the University of Southern California. He also holds a Bachelor of Science in Biology from Bowdoin College and a Master of Science in Chemistry from Boston College. His educational qualifications support his extensive career in finance and the pharmaceutical industry.
Expertise in Financial Processes
Felsch is recognized for his expertise in financial planning and analysis (FP&A), corporate accounting, and financial reporting. He has a strong track record of implementing scalable financial processes that support business growth. His ability to build high-performance finance teams in publicly traded companies is a notable aspect of his professional profile.
Career in the Pharmaceutical Industry
With over 20 years of experience in the pharmaceutical industry, Rob Felsch has worked in various capacities related to quality, regulatory, and CMC areas. His previous roles include Vice President of CMC at Flexion Therapeutics and Vice President of Quality at Idenix Pharmaceuticals. He has also contributed to GelTex Pharmaceuticals and Trine Pharmaceuticals, showcasing his diverse experience in the sector.